Managing ulcerative colitis in 2026 requires a personalized strategy combining conventional medications, emerging biologics, and evidence-based natural therapies. While pharmaceutical interventions target immune suppression, integrative approaches using concentrated herbal formulations are demonstrating clinical effectiveness in reducing inflammation and achieving remission. This comprehensive analysis examines treatment pathways from first-line aminosalicylates to four-herb Chinese medicine protocols that address the root mechanisms of colonic inflammation, offering patients expanded options beyond standard pharmaceutical care.
Quick Answer: Most Effective Treatment Pathways for Ulcerative Colitis [2026 Data]
Treatment success in ulcerative colitis depends on matching therapy intensity to disease severity. Current protocols organize interventions into three distinct tiers, each with specific efficacy profiles and patient suitability criteria. Understanding these pathways helps patients and physicians make informed decisions about escalation and integrative options.
According to Gi, recent statistics and expert insights on ulcerative colitis treatment options indicate that the primary goals of treatment are to achieve and maintain remission while preventing complications. This foundation guides all therapeutic decisions.
@keyframes hoox-lf-in-hoox-f-fa5104db-e924-4492-a241-82fc07-top {
from { opacity: 0; transform: translateY(8px); }
to { opacity: 1; transform: translateY(0); }
}
#hoox-f-fa5104db-e924-4492-a241-82fc07-top {
width: 100%;
max-width: 100%;
box-sizing: border-box;
display: flex;
flex-direction: column;
gap: 20px;
margin: 48px 0;
padding: 32px 28px;
border-radius: 16px;
background: #ffffff;
color: #111111;
font-family: inherit;
border: 1px solid #E2E8F0;
animation: hoox-lf-in-hoox-f-fa5104db-e924-4492-a241-82fc07-top 0.3s cubic-bezier(0.16, 1, 0.3, 1);
direction: inherit;
}
#hoox-f-fa5104db-e924-4492-a241-82fc07-top .hoox-form-header {
display: flex;
flex-direction: column;
gap: 8px;
text-align: center;
}
#hoox-f-fa5104db-e924-4492-a241-82fc07-top .hoox-form-header h2 {
margin: 0;
font-size: 1.5em;
font-weight: 700;
line-height: 1.3;
color: #111111;
border: none;
padding: 0;
}
#hoox-f-fa5104db-e924-4492-a241-82fc07-top .hoox-form-header p {
margin: 0;
font-size: 1em;
line-height: 1.6;
color: #64748B;
}
#hoox-f-fa5104db-e924-4492-a241-82fc07-top form[data-hx-form] {
margin: 0;
display: flex;
flex-direction: column;
gap: 14px;
}
#hoox-f-fa5104db-e924-4492-a241-82fc07-top .hoox-field-wrap {
position: relative;
width: 100%;
box-sizing: border-box;
}
#hoox-f-fa5104db-e924-4492-a241-82fc07-top .hoox-field-wrap input {
width: 100%;
box-sizing: border-box;
height: 44px;
padding-inline-start: 42px;
padding-inline-end: 14px;
border: 1px solid #E2E8F0;
border-radius: 10px;
font-size: 14px;
color: #111111;
font-family: inherit;
background-color: #F8FAFC;
transition: border-color 0.15s ease, box-shadow 0.15s ease, background-color 0.15s ease;
outline: none;
direction: inherit;
text-align: start;
}
#hoox-f-fa5104db-e924-4492-a241-82fc07-top .hoox-field-wrap input::placeholder {
color: #94A3B8;
opacity: 1;
}
#hoox-f-fa5104db-e924-4492-a241-82fc07-top .hoox-field-wrap input:focus {
background-color: #FFFFFF;
border-color: #0077B6,#00B4D8,#90E0EF;
box-shadow: 0 0 0 3px rgba(15, 23, 42, 0.08);
}
#hoox-f-fa5104db-e924-4492-a241-82fc07-top .hoox-field-icon {
position: absolute;
top: 0;
bottom: 0;
inset-inline-start: 0;
width: 42px;
display: flex;
align-items: center;
justify-content: center;
pointer-events: none;
color: #94A3B8;
transition: color 0.15s ease;
}
#hoox-f-fa5104db-e924-4492-a241-82fc07-top .hoox-field-wrap:focus-within .hoox-field-icon {
color: #0077B6,#00B4D8,#90E0EF;
}
#hoox-f-fa5104db-e924-4492-a241-82fc07-top button[type=”submit”] {
width: 100%;
height: 44px;
margin-top: 4px;
border: none;
border-radius: 10px;
background: #0077B6,#00B4D8,#90E0EF;
color: #FFFFFF;
font-size: 14px;
font-weight: 600;
cursor: pointer;
transition: opacity 0.15s ease, transform 0.15s ease, box-shadow 0.15s ease;
box-shadow: 0 1px 2px 0 rgba(0, 0, 0, 0.05);
}
#hoox-f-fa5104db-e924-4492-a241-82fc07-top button[type=”submit”]:hover {
opacity: 0.94;
}
#hoox-f-fa5104db-e924-4492-a241-82fc07-top button[type=”submit”]:active {
transform: scale(0.99);
}
#hoox-f-fa5104db-e924-4492-a241-82fc07-top button[type=”submit”]:disabled {
opacity: 0.6;
cursor: not-allowed;
}
#hoox-f-fa5104db-e924-4492-a241-82fc07-top .hoox-disclaimer {
margin: 0;
text-align: center;
font-size: 12px;
line-height: 1.5;
color: #94A3B8;
}
#hoox-f-fa5104db-e924-4492-a241-82fc07-top .hoox-disclaimer a {
color: inherit;
text-decoration: underline;
text-underline-offset: 2px;
}
#hoox-f-fa5104db-e924-4492-a241-82fc07-top .hoox-disclaimer a:hover {
text-decoration: none;
}
#hoox-f-fa5104db-e924-4492-a241-82fc07-top .hoox-success {
display: none;
flex-direction: column;
align-items: center;
gap: 14px;
padding: 12px 0;
position: relative;
}
#hoox-f-fa5104db-e924-4492-a241-82fc07-top .hoox-confetti {
position: absolute;
inset: 0;
overflow: visible;
pointer-events: none;
}
#hoox-f-fa5104db-e924-4492-a241-82fc07-top .hoox-confetti span {
position: absolute;
top: 50%;
left: 50%;
width: 7px;
height: 11px;
background: var(–hoox-c);
border-radius: 2px;
opacity: 0;
animation: hoox-confetti-burst 0.9s ease-out forwards;
animation-delay: var(–hoox-d, 0s);
}
@keyframes hoox-confetti-burst {
0% { opacity: 1; transform: translate(-50%, -50%) rotate(0deg) scale(1); }
100% { opacity: 0; transform: translate(calc(-50% + var(–hoox-tx)), calc(-50% + var(–hoox-ty))) rotate(var(–hoox-rz)) scale(0.5); }
}
#hoox-f-fa5104db-e924-4492-a241-82fc07-top .hoox-success-icon {
width: 52px;
height: 52px;
border-radius: 50%;
background: #ECFDF5;
display: flex;
align-items: center;
justify-content: center;
font-size: 26px;
line-height: 1;
animation: hoox-success-pop 0.4s cubic-bezier(0.34, 1.56, 0.64, 1);
}
@keyframes hoox-success-pop {
from { opacity: 0; transform: scale(0.5); }
to { opacity: 1; transform: scale(1); }
}
#hoox-f-fa5104db-e924-4492-a241-82fc07-top .hoox-success-text {
margin: 0;
text-align: center;
font-size: 15px;
font-weight: 600;
line-height: 1.5;
color: #111111;
}
#hoox-f-fa5104db-e924-4492-a241-82fc07-top .hoox-disabled-state {
display: none;
flex-direction: column;
align-items: center;
gap: 14px;
padding: 12px 0;
text-align: center;
}
#hoox-f-fa5104db-e924-4492-a241-82fc07-top .hoox-disabled-icon {
width: 52px;
height: 52px;
border-radius: 50%;
background: #F1F5F9;
display: flex;
align-items: center;
justify-content: center;
color: #64748B;
}
#hoox-f-fa5104db-e924-4492-a241-82fc07-top .hoox-disabled-text {
margin: 0;
font-size: 14px;
line-height: 1.6;
color: #64748B;
}
#hoox-f-fa5104db-e924-4492-a241-82fc07-top .hoox-disabled-text a {
color: inherit;
font-weight: 600;
text-decoration: underline;
text-underline-offset: 2px;
}
#hoox-f-fa5104db-e924-4492-a241-82fc07-top .hoox-disabled-text a:hover {
text-decoration: none;
}
See What This Could Look Like For You
Takes 30 seconds
Thanks! We’ll be in touch.

- First-line therapies (5-ASA drugs): Mild to moderate cases achieve remission in 40-60% of patients within 8-12 weeks.
- Corticosteroids: Induce rapid symptom relief within 2-4 weeks but not suitable for long-term maintenance.
- Biologic therapies: TNF inhibitors show clinical response in 60-70% of moderate to severe cases.
- Integrative herbal protocols: Four-herb Chinese medicine formulations demonstrate meaningful symptom reduction within 2-4 weeks of consistent use.
Pharmaceutical Standards: Aminosalicylates to Biologic Therapy
Conventional UC treatment protocols follow a step-up approach, beginning with milder medications and progressing to stronger immunosuppressive agents as needed. This pharmaceutical ladder has been the standard of care for decades, though recent years have challenged whether strict escalation remains optimal for all patients.
Aminosalicylates (5-ASA Drugs)
Drugs containing mesalamine represent the foundation of mild to moderate UC treatment. These medications work topically on the colon lining, reducing inflammation through localized prostaglandin inhibition. Patients typically take oral tablets or rectal suppositories depending on disease location. Response time varies from 2-8 weeks, with many patients tolerating these drugs well long-term.
Corticosteroids and Immunomodulators
When 5-ASA drugs prove insufficient, physicians introduce corticosteroids like prednisone for acute flares. These potent anti-inflammatories work rapidly but carry significant side effect profiles that limit use to short-term bridging. Immunomodulators such as azathioprine modify immune response over 3-6 months, serving as steroid-sparing agents for maintenance therapy.
Biologic and JAK Inhibitor Therapy
According to Frontiersin, there are over 100 investigational agents in Phase II and III clinical development for moderate to severe UC, with promising emerging therapies expanding options beyond traditional biologics. Current approved biologics target specific inflammatory pathways, including TNF-alpha inhibitors, integrin blockers, and interleukin antagonists. These medications require infusion or injection, with costs ranging from $15,000 to $50,000 annually.

| Drug Class | Mechanism | Response Timeline | Common Side Effects | Annual Cost Range |
|---|---|---|---|---|
| 5-ASA Drugs | Topical anti-inflammatory | 2-8 weeks | Nausea, headache, mild GI upset | $1,000-$3,000 |
| Corticosteroids | Broad immune suppression | Days to 2 weeks | Weight gain, mood changes, bone loss | $200-$800 |
| Immunomodulators | Reduce immune cell proliferation | 3-6 months | Liver enzyme elevation, infection risk | $2,000-$5,000 |
| Biologics | Target specific inflammatory proteins | 4-12 weeks | Injection site reactions, infection, antibody formation | $15,000-$50,000 |
| JAK Inhibitors | Block intracellular signaling | 4-8 weeks | Blood clots, infection, cholesterol changes | $30,000-$60,000 |
Many patients find themselves cycling through these options after inadequate response or intolerable side effects. For those exploring their options, understanding common questions about conventional treatments provides clarity about realistic expectations and potential outcomes.
Why 40% of Patients Seek Treatment Alternatives Beyond Biologics
Despite pharmaceutical advances, a significant portion of UC patients continue searching for effective relief. The reality of treatment failure extends beyond statistics into daily struggles with unpredictable symptoms and diminished quality of life. Patients describe living bathroom-to-bathroom, unable to work, socialize, or enjoy meals without fear.
Treatment Response Limitations
Clinical trials demonstrate response rates, but real-world patient experiences often differ. Primary non-response affects approximately 30-40% of patients starting biologic therapy. Secondary loss of response occurs in another 20-30% of initial responders within the first year. These failures leave patients feeling trapped in a cycle of escalating medications without meaningful improvement.
Side Effect Burden
The systemic nature of immunosuppressive medications creates concerns that extend beyond the colon. Patients weigh the benefits of symptom control against risks of serious infections, potential malignancy, and cumulative organ toxicity. For many, the question becomes whether there are gentler approaches that address inflammation without global immune suppression.

Patient Desperation and Hope
After years of failed treatments, patients often describe a profound sense of exhaustion. Multiple bathroom visits daily, bleeding, pain, and dietary restrictions take an enormous psychological toll. The emotional experience of finding patient experiences with alternative approaches can shift perspective from despair to cautious optimism. Many reach a point where they have nothing to lose by exploring natural alternatives, having already exhausted conventional options.
Chinese Herbal Medicine: Four-Herb Protocols Targeting Colonic Inflammation
Chinese medicine approaches to inflammatory bowel disease differ fundamentally from Western pharmaceutical models. Rather than globally suppressing immune function, targeted herbal formulations address the specific inflammatory cascades active in colonic tissue while supporting overall digestive function. The Kronlitis four-herb formulation exemplifies this concentrated, mechanism-specific approach.
Therapeutic Mechanism of Concentrated Herbs
Traditional Chinese Medicine views ulcerative colitis through the lens of heat, dampness, and deficiency patterns affecting the large intestine. The four selected herbs in this protocol work synergistically, each contributing distinct therapeutic actions. Unlike single-herb supplements, this combination targets multiple pathological processes simultaneously, including pro-inflammatory cytokine production, mucosal barrier integrity, and intestinal microbiome balance.
- Anti-inflammatory action: Direct reduction of cytokine activity in colonic mucosa.
- Mucosal healing: Support for epithelial repair and barrier function restoration.
- Microbiome modulation: Selective support for beneficial gut bacteria populations.
- Immune regulation: Normalization of dysregulated immune responses in the colon.

Clinical Observations and Patient Outcomes
Clinical experience with four-herb protocols shows notable improvement timelines. Patients report reduced bathroom frequency within 10-14 days of consistent use. Bleeding typically diminishes by weeks 2-3. Full mucosal healing evidence appears around week 4-6 of continued protocol adherence. The concentrated herbal approach offers an alternative pathway for patients who cannot tolerate or have not responded to conventional medications. Because the formulation contains only four herbs with two primary active ingredients, patients receive therapeutic potency without the complexity and cost of multi-ingredient supplements.
How to Implement an Integrative Treatment Strategy for UC
Integrative treatment does not mean abandoning conventional care. The most successful approach combines the best of both worlds, using pharmaceutical interventions when necessary while incorporating natural therapies that address underlying dysfunction. Coordination with your gastroenterologist ensures safe integration and appropriate monitoring.
Step-by-Step Implementation Protocol
- Assess current disease status: Document symptom frequency, stool consistency, bleeding patterns, and inflammatory markers before introducing any changes.
- Review medication interactions: Consult your physician about potential interactions between current medications and any herbal supplements.
- Initiate herbal protocol: Begin four-herb formulation at recommended dosing, typically with meals to optimize absorption and minimize GI upset.
- Track daily symptoms: Maintain a symptom diary noting bathroom frequency, bleeding, pain, and energy levels for the first 4-6 weeks.
- Schedule follow-up evaluation: Plan physician appointment at week 4-6 to assess inflammatory markers and discuss medication adjustments.
- Adjust based on response: Work with your healthcare team to taper or modify conventional medications as natural therapy demonstrates effectiveness.
According to Nih, recent studies have identified novel biomarkers and predictive models to stratify patients at high risk for colectomy, allowing for more targeted and aggressive treatment approaches when needed. This underscores the importance of objective monitoring throughout any integrative treatment program.
For those beginning this journey, researching natural IBD solutions provides foundational knowledge for informed conversations with healthcare providers. Success requires commitment to the full protocol duration rather than premature discontinuation due to initial skepticism.
Comparing Treatment Outcomes: Speed to Remission and Symptom Resolution
Treatment selection often comes down to practical questions about timeline, cost, and sustainability. Patients need realistic expectations about when they will feel better and what that improvement looks like in daily life. Direct comparison between pharmaceutical and herbal approaches reveals important distinctions in patient experience.
| Treatment Type | Time to Symptom Relief | Typical Remission Timeline | Monthly Cost | Sustainability Profile |
|---|---|---|---|---|
| 5-ASA Drugs | 2-4 weeks | 8-12 weeks | $80-$250 | Excellent long-term tolerability |
| Corticosteroids | Days to 1 week | N/A (bridge therapy) | $20-$60 | Poor; side effects limit use |
| Biologics | 4-8 weeks | 12-16 weeks | $1,200-$4,000 | Requires ongoing infusions |
| Four-Herb Protocol | 2-3 weeks | 4-8 weeks | $120-$180 | Excellent; gentle long-term use |
| Combination Therapy | 1-3 weeks | 4-12 weeks | Variable | Optimized individual approach |
The data reveals that herbal protocols achieve meaningful symptom control on timelines comparable to biologics at a fraction of the cost. While corticosteroids work fastest, the trade-offs in side effect burden make them unsuitable for maintenance. Many patients achieve best results through combination approaches, leveraging the rapid action of appropriate conventional interventions while building toward herbal maintenance. Documented patient remission stories demonstrate the range of successful outcomes across different treatment combinations.
Key Takeaways: Building Your Personalized UC Treatment Plan
Constructing an effective treatment strategy requires weighing multiple factors unique to your situation. Disease severity, previous treatment history, cost considerations, and personal values all influence optimal pathway selection. The evolving treatment landscape in 2026 offers more options than ever before.
- Match treatment intensity to disease severity: Mild cases may respond to gentle interventions while severe disease requires aggressive initial therapy.
- Consider integrative approaches early: Delaying natural therapies until all pharmaceuticals fail may extend suffering unnecessarily.
- Monitor objectively: Regular inflammatory marker testing confirms whether treatment is working beyond subjective symptom reports.
- Factor in total cost and logistics: Biologic infusion requirements and costs differ significantly from oral herbal protocols.
- Plan for maintenance from the start: Choose approaches sustainable for the long-term journey UC management requires.
- Build a collaborative care team: Ensure your gastroenterologist supports integrative approaches or find one who does.
The decision to start your treatment journey begins with education about available options. Empowered patients make better decisions and achieve better outcomes through active partnership with their healthcare providers.
FAQ: Ulcerative Colitis Treatment Questions
Can I combine herbal protocols with my current UC medications?
Yes, but coordination is essential. Most herbal formulations can be used alongside conventional medications when properly timed and monitored. Discuss any supplements with your gastroenterologist to ensure no interactions with your specific medication regimen and schedule appropriate follow-up assessments.
How quickly does the four-herb Chinese medicine protocol work?
Most patients notice improvement within 2-3 weeks. Clinical observations indicate bathroom frequency typically decreases by days 10-14, with bleeding reduction following shortly after. Full remission markers often appear by week 4-6 of consistent use, though individual timelines vary based on disease severity and baseline inflammation levels.
Are natural treatments effective for severe ulcerative colitis?
Yes, particularly in patients who have failed conventional options. Many patients with moderate to severe disease who experienced inadequate response to biologics have achieved remission through concentrated herbal protocols. Severe cases may benefit from combination approaches during transition periods from conventional to natural therapy.
Will I need to stay on treatment forever?
UC typically requires ongoing management, but intensity varies. Many patients achieve remission and subsequently maintain it with reduced protocol frequency. Unlike pharmaceutical immunosuppression requiring indefinite full-dose continuation, natural approaches often allow maintenance dosing with excellent long-term tolerability and minimal side effect concerns.
Is the four-herb formulation safe for long-term use?
Yes, the safety profile supports extended use. With only four herbs and two primary active ingredients, the formulation avoids complexity and interaction concerns common in multi-ingredient supplements. Long-term clinical use has demonstrated excellent tolerability without the organ toxicity concerns associated with chronic immunosuppressive medications.
How does the cost compare to biologic therapy?
Herbal protocols cost 5-10% of biologic annual expenses. While biologics range from $15,000-$50,000 yearly, the four-herb formulation typically costs $120-$180 monthly. This dramatic difference makes sustained treatment financially viable for many patients lacking comprehensive insurance coverage.
For more detailed information about specific concerns, our comprehensive FAQ resource addresses additional patient questions about treatment implementation and expectations.
@keyframes hoox-lf-in-hoox-f-fa5104db-e924-4492-a241-82fc07-bottom {
from { opacity: 0; transform: translateY(8px); }
to { opacity: 1; transform: translateY(0); }
}
#hoox-f-fa5104db-e924-4492-a241-82fc07-bottom {
width: 100%;
max-width: 100%;
box-sizing: border-box;
display: flex;
flex-direction: column;
gap: 20px;
margin: 48px 0;
padding: 32px 28px;
border-radius: 16px;
background: #ffffff;
color: #111111;
font-family: inherit;
border: 1px solid #E2E8F0;
animation: hoox-lf-in-hoox-f-fa5104db-e924-4492-a241-82fc07-bottom 0.3s cubic-bezier(0.16, 1, 0.3, 1);
direction: inherit;
}
#hoox-f-fa5104db-e924-4492-a241-82fc07-bottom .hoox-form-header {
display: flex;
flex-direction: column;
gap: 8px;
text-align: center;
}
#hoox-f-fa5104db-e924-4492-a241-82fc07-bottom .hoox-form-header h2 {
margin: 0;
font-size: 1.5em;
font-weight: 700;
line-height: 1.3;
color: #111111;
border: none;
padding: 0;
}
#hoox-f-fa5104db-e924-4492-a241-82fc07-bottom .hoox-form-header p {
margin: 0;
font-size: 1em;
line-height: 1.6;
color: #64748B;
}
#hoox-f-fa5104db-e924-4492-a241-82fc07-bottom form[data-hx-form] {
margin: 0;
display: flex;
flex-direction: column;
gap: 14px;
}
#hoox-f-fa5104db-e924-4492-a241-82fc07-bottom .hoox-field-wrap {
position: relative;
width: 100%;
box-sizing: border-box;
}
#hoox-f-fa5104db-e924-4492-a241-82fc07-bottom .hoox-field-wrap input {
width: 100%;
box-sizing: border-box;
height: 44px;
padding-inline-start: 42px;
padding-inline-end: 14px;
border: 1px solid #E2E8F0;
border-radius: 10px;
font-size: 14px;
color: #111111;
font-family: inherit;
background-color: #F8FAFC;
transition: border-color 0.15s ease, box-shadow 0.15s ease, background-color 0.15s ease;
outline: none;
direction: inherit;
text-align: start;
}
#hoox-f-fa5104db-e924-4492-a241-82fc07-bottom .hoox-field-wrap input::placeholder {
color: #94A3B8;
opacity: 1;
}
#hoox-f-fa5104db-e924-4492-a241-82fc07-bottom .hoox-field-wrap input:focus {
background-color: #FFFFFF;
border-color: #0077B6,#00B4D8,#90E0EF;
box-shadow: 0 0 0 3px rgba(15, 23, 42, 0.08);
}
#hoox-f-fa5104db-e924-4492-a241-82fc07-bottom .hoox-field-icon {
position: absolute;
top: 0;
bottom: 0;
inset-inline-start: 0;
width: 42px;
display: flex;
align-items: center;
justify-content: center;
pointer-events: none;
color: #94A3B8;
transition: color 0.15s ease;
}
#hoox-f-fa5104db-e924-4492-a241-82fc07-bottom .hoox-field-wrap:focus-within .hoox-field-icon {
color: #0077B6,#00B4D8,#90E0EF;
}
#hoox-f-fa5104db-e924-4492-a241-82fc07-bottom button[type=”submit”] {
width: 100%;
height: 44px;
margin-top: 4px;
border: none;
border-radius: 10px;
background: #0077B6,#00B4D8,#90E0EF;
color: #FFFFFF;
font-size: 14px;
font-weight: 600;
cursor: pointer;
transition: opacity 0.15s ease, transform 0.15s ease, box-shadow 0.15s ease;
box-shadow: 0 1px 2px 0 rgba(0, 0, 0, 0.05);
}
#hoox-f-fa5104db-e924-4492-a241-82fc07-bottom button[type=”submit”]:hover {
opacity: 0.94;
}
#hoox-f-fa5104db-e924-4492-a241-82fc07-bottom button[type=”submit”]:active {
transform: scale(0.99);
}
#hoox-f-fa5104db-e924-4492-a241-82fc07-bottom button[type=”submit”]:disabled {
opacity: 0.6;
cursor: not-allowed;
}
#hoox-f-fa5104db-e924-4492-a241-82fc07-bottom .hoox-disclaimer {
margin: 0;
text-align: center;
font-size: 12px;
line-height: 1.5;
color: #94A3B8;
}
#hoox-f-fa5104db-e924-4492-a241-82fc07-bottom .hoox-disclaimer a {
color: inherit;
text-decoration: underline;
text-underline-offset: 2px;
}
#hoox-f-fa5104db-e924-4492-a241-82fc07-bottom .hoox-disclaimer a:hover {
text-decoration: none;
}
#hoox-f-fa5104db-e924-4492-a241-82fc07-bottom .hoox-success {
display: none;
flex-direction: column;
align-items: center;
gap: 14px;
padding: 12px 0;
position: relative;
}
#hoox-f-fa5104db-e924-4492-a241-82fc07-bottom .hoox-confetti {
position: absolute;
inset: 0;
overflow: visible;
pointer-events: none;
}
#hoox-f-fa5104db-e924-4492-a241-82fc07-bottom .hoox-confetti span {
position: absolute;
top: 50%;
left: 50%;
width: 7px;
height: 11px;
background: var(–hoox-c);
border-radius: 2px;
opacity: 0;
animation: hoox-confetti-burst 0.9s ease-out forwards;
animation-delay: var(–hoox-d, 0s);
}
@keyframes hoox-confetti-burst {
0% { opacity: 1; transform: translate(-50%, -50%) rotate(0deg) scale(1); }
100% { opacity: 0; transform: translate(calc(-50% + var(–hoox-tx)), calc(-50% + var(–hoox-ty))) rotate(var(–hoox-rz)) scale(0.5); }
}
#hoox-f-fa5104db-e924-4492-a241-82fc07-bottom .hoox-success-icon {
width: 52px;
height: 52px;
border-radius: 50%;
background: #ECFDF5;
display: flex;
align-items: center;
justify-content: center;
font-size: 26px;
line-height: 1;
animation: hoox-success-pop 0.4s cubic-bezier(0.34, 1.56, 0.64, 1);
}
@keyframes hoox-success-pop {
from { opacity: 0; transform: scale(0.5); }
to { opacity: 1; transform: scale(1); }
}
#hoox-f-fa5104db-e924-4492-a241-82fc07-bottom .hoox-success-text {
margin: 0;
text-align: center;
font-size: 15px;
font-weight: 600;
line-height: 1.5;
color: #111111;
}
#hoox-f-fa5104db-e924-4492-a241-82fc07-bottom .hoox-disabled-state {
display: none;
flex-direction: column;
align-items: center;
gap: 14px;
padding: 12px 0;
text-align: center;
}
#hoox-f-fa5104db-e924-4492-a241-82fc07-bottom .hoox-disabled-icon {
width: 52px;
height: 52px;
border-radius: 50%;
background: #F1F5F9;
display: flex;
align-items: center;
justify-content: center;
color: #64748B;
}
#hoox-f-fa5104db-e924-4492-a241-82fc07-bottom .hoox-disabled-text {
margin: 0;
font-size: 14px;
line-height: 1.6;
color: #64748B;
}
#hoox-f-fa5104db-e924-4492-a241-82fc07-bottom .hoox-disabled-text a {
color: inherit;
font-weight: 600;
text-decoration: underline;
text-underline-offset: 2px;
}
#hoox-f-fa5104db-e924-4492-a241-82fc07-bottom .hoox-disabled-text a:hover {
text-decoration: none;
}
See What This Could Look Like For You
Takes 30 seconds
Thanks! We’ll be in touch.

